BJOG : an international journal of obstetrics and gynaecology
-
To assess the changes in antimüllerian hormone (AMH) levels after ablation for symptomatic uterine fibroids and adenomyosis using ultrasound-guided high-intensity focused ultrasound (USgHIFU). ⋯ HIFU ablation is a safe and effective treatment for patients with uterine fibroids and adenomyosis that does not affect ovarian function.
-
Randomized Controlled Trial
Enhancing ablation effects of a microbubble contrast agent on high-intensity focused ultrasound: an experimental and clinical study.
To investigate the relationship between SonoVue ablation enhancement effects on high-intensity focused ultrasound (HIFU) and the concentration of SonoVue and timing of HIFU. ⋯ SonoVue, a microbubble contrast agent, enhanced the ablation effects of HIFU treatment; the optimal time to begin HIFU sonication appears to be 1 minute after the administration of SonoVue.
-
To evaluate the tolerability of cervical insulin-like growth factor binding protein 1 (IGFBP-1) and its value as a predictor of successful labour induction, compared with Bishop score and transvaginal ultrasound (TVUS) cervical length. ⋯ IGFBP-1: a stronger independent predictor of labour induction success than Bishop score or cervical sonography.
-
To evaluate the effectiveness of intrauterine balloon tamponade (IUBT) for management of severe postpartum haemorrhage (PPH). To identify the factors predicting IUBT failure. ⋯ Intrauterine balloon tamponade is effective for achieving haemostasis in intractable postpartum haemorrhages.
-
To examine the characteristics and experiences of women in Ireland and Northern Ireland seeking at-home medical termination of pregnancy (TOP) using online telemedicine. ⋯ Irish and Northern Irish women completing at-home medical TOP report benefits for health, wellbeing and autonomy.